In vitro cytotoxicity of polyphosphoester as a novel injectable alveolar replacement material.

Department of Orthodontics, Tongji Hospital, Wuhan 430022, China.
Journal of Huazhong University of Science and Technology (Impact Factor: 0.78). 10/2008; 28(5):604-7. DOI: 10.1007/s11596-008-0526-6
Source: PubMed

ABSTRACT The aim of this study was to investigate the in vitro cytotoxicity of polyphosphoester polymer used as a novel injectable alveolar bone substitutes for controlled delivery of tetracycline. Cell culture medium was exposed to the polymer (0.01-10 mg/mL) for 24 h. The L-929 mouse fibroblasts were then exposed to the treated cell culture medium for 24 h. Finally, cell viability and growth were assessed by using MTT assay and Alamar Blue assay. No significant cytotoxicity of the polyphosphoester against L-929 mouse fibroblasts was observed at a concentration up to 10 mg/mL (P>0.05). The two evaluation methods showed no significant differences (P>0.05). This study suggests that polyphosphoester does not demonstrate any significant toxic effects to cells in vitro and has the potential to be used both as a medical device and as scaffolds in tissue engineering applications.

1 Bookmark
  • [Show abstract] [Hide abstract]
    ABSTRACT: Poly(D,L-lactide-co-glycolide) (PLGA, 75/25) microspheres loaded with bovine serum albumin (BSA) were prepared using the W/O/W emulsification solvent evaporation technique. The cytotoxicity in vitro of PLGA microspheres was investigated and the BSA release from PLGA microspheres was also studied. Scanning electron micrographs showed that the PLGA microspheres were regular and the surface was smooth. BSA release typically began with an initial burst and then became steady. Analysis of the PLGA microspheres cytotoxicity showed that they had no cytotoxic effect and behaved very similar to the negative control of polystyrene. The hemolysis rate of the PLGA microspheres was 0.148%, suggesting it had no potential to induce hemolysis. The results show that PLGA microspheres may provide a useful controlled release protein drug system for used in pharmaceutics.
    Journal of Macromolecular Science Part B 06/2011; Part B: Physics(Vol. 50):1154-1161. · 0.62 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The hydrogel based on polyvinyl alcohol (PVA) and collagen was prepared by using a freeze-dried method. To evaluate the biological safety of the PVA/collagen hydrogel, which has a potential application in tissue substitute, cell viability and growth were assessed by using methylthiazoletetrazolium (MTT) assay and Alamar Blue assay; Micronucleus test was reckoned to identify genotoxicity, and sensitivity test was aimed to detect allergic response to skin. The results demonstrated that no significant cytotoxicity of the PVA/collagen hydrogen against L929 mouse fibroblasts was observed. The micronucleus frequency of PVA/collagen was (2.5 ± 0.79)‰, which showed no genotoxic effects either. In addition, there was no allergic response in long-term application. This study suggests that PVA/collagen hydrogen does not demonstrate any significant toxic effects to fibroblastic cells in-vitro and has the potential to be used as scaffolds in tissue engineering applications.
    Polymer-Plastics Technology and Engineering 01/2011; 50(3):245-250. · 1.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cathelicidin-BF-30 (BF-30), a water-soluble peptide isolated from the snake venom of Bungarus fasciatus containing 30 amino acid residues, was incorporated in poly(D,L-lactide-co-glycolide) (PLGA) 75∶25 microspheres (MS) prepared by a water in oil in water W/O/W emulsification solvent extraction method. The aim of this work was to investigate the stability of BF-30 after encapsulation. D-trehalose was used as an excipient to stabilize the peptide. The MS obtained were mostly under 2 µm in size and the encapsulation efficiency was 88.50±1.29%. The secondary structure of the peptide released in vitro was determined to be nearly the same as the native peptide using Circular Dichroism (CD). The ability of BF-30 to inhibit the growth of Escherichia coli was also maintained. The cellular relative growth and hemolysis rates were 92.16±3.55% and 3.52±0.45% respectively.
    PLoS ONE 06/2014; 9(6):e100809. · 3.53 Impact Factor

Similar Publications